A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers

NCT01821066 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PD-0332991 alone
DRUG: Tamoxifen 60 mg
DRUG: Tamoxifen 20 mg
DRUG: PD-0332991 combination

Sponsor

Pfizer